Psychosocial considerations in pediatric autoimmune liver disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

1. The Development and Co-Production of a Caregiver Coping Resource for Pediatric Inflammatory Bowel Disease and Autoimmune Liver Disease.Learning health systems · 2026
   Article
2. Autoimmune hepatitis: Towards a personalized treatment.World journal of hepatology · 2024
   Review
3. B cell depletion for autoimmune liver diseases: A retrospective review of indications and outcomes.JPGN reports · 2024
   Article
4. Psychosocial considerations in pediatric autoimmune liver disease.Clinical liver disease · 2022
   Review
5. Adherence to Medication in Children With Liver Disease in India, the First Report - Every Journey Starts With a First Step!Journal of clinical and experimental hepatology
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.